However, this paper focuses on genes associated with hereditary cancer risks (BRCA1, BRCA2, CHEK2, APC, MSH2, MSH6, and GREM1) that do not have pathognomonic features (i.e., the BLM gene which is associated with growth deficiency and a butterfly rash). This evidence concerns the gene MSH2 and hereditary cancer.